A PYMNTS Company

Australia: Court dismisses Pfizer of anti-competitive case

By  |  February 25, 2015

The federal court has dismissed a case against Pfizer Australia which claimed the pharmaceutical giant misused its market power and engaged in anti-competitive conduct in the way it supplied one of its blockbuster drugs to pharmacists.

The Australian Competition and Consumer Commission (alleged that in offering heavy discounts just before losing its patent over Lipitor, Pfizer had aimed to deter or prevent competitors entering the market.

The commission also alleged Pfizer had engaged in anti-competitive conduct.

But on Wednesday Justice Geoffrey Flick dismissed the case, saying there was not enough evidence to prove the claims.

 

Full Content: The Wall Street Journal

 

Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.